CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash Flows from Operating Activities
Net income (loss)	$ (108,032)	$ (67,323)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss (gain) on debt modification and extinguishment, net	35,335	0
Depreciation and amortization, net	191,171	178,746
Asset impairment:	2,364	1,708
Deferred income tax (benefit) provision	(1,905)	(360)
Operating lease expense adjustment	(8,699)	(26,572)
Change in fair value of derivatives	1,113	(2,742)
Loss (gain) on sale of assets, net	(43)	(903)
Non-cash stock-based compensation expense	7,068	7,248
Property and casualty insurance income	(3,487)	(2,688)
Changes in operating assets and liabilities:
Accounts receivable, net	(4,169)	(1,390)
Prepaid expenses and other assets, net	(8,500)	(855)
Prepaid insurance premiums financed with notes payable	(15,094)	(15,702)
Trade accounts payable and accrued expenses	7,755	(14,380)
Refundable fees and deferred revenue	757	(1,563)
Operating lease assets and liabilities for lessor capital expenditure reimbursements	11,332	1,300
Net cash provided by operating activities	106,966	54,524
Cash Flows from Investing Activities
Purchase of marketable securities	0	(19,591)
Sale and maturities of marketable securities	20,000	30,000
Capital expenditures, net of related payables	(96,283)	(95,973)
Acquisition of assets	(311,028)	0
Proceeds from sale of assets, net	1,047	7,017
Property and casualty insurance proceeds	3,487	2,704
Change in lease acquisition deposits, net	5,000	0
Purchase of interest rate cap instruments	(2,681)	(8,513)
Proceeds from interest rate cap instruments	3,197	9,129
Other	107	(176)
Net cash provided by (used in) investing activities	(377,154)	(75,403)
Cash Flows from Financing Activities
Proceeds from debt	320,739	81,271
Repayment of debt and financing lease obligations	(95,351)	(41,077)
Payment of financing costs, net of related payables	(6,708)	(3,074)
Payments of employee taxes for withheld shares	(4,770)	(3,405)
Net cash provided by (used in) financing activities	213,910	33,715
Net increase (decrease) in cash, cash equivalents, and restricted cash	(56,278)	12,836
Cash, cash equivalents, and restricted cash at beginning of period	379,840	349,668
Cash, cash equivalents, and restricted cash at end of period	$ 323,562	$ 362,504